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Abstract
Background: Among adolescent novice smokers, craving is often the first, and is the most reported, symptom of
nicotine dependence. Until now, little has been known about the development of craving symptoms in novice
smokers. The aim of this study was to identify specific genetic (i.e., DRD2 Taq1A, DRD4 48 bp VNTR, and OPRM1
A118G polymorphisms) and environmental mechanisms that underlie the emergence of both cue-induced and
cognitive craving among adolescent novice smokers.
Method: A five-wave longitudinal, genetically-informed survey study was conducted with intervals of four months. The
sample included 376 early adolescent smokers (12–13 years of age at baseline). Self-report questionnaires were completed
regarding smoking behavior, observed parental smoking behavior, and both cue-induced and cognitive craving.
Results: Data were analyzed with a latent growth curve approach. For both cue-induced and cognitive craving, significant
interaction effects were found for DRD2 Taq1A with parental smoke exposure. A1-allele carriers did not seem to be
influenced by the environment with regard to craving development. Adolescents who are homozygous for the A2-allele
and who are more exposed to parental smoking experience the highest levels of both types of craving over time. No
significant interaction effects were found between parental smoke exposure and DRD4 48 bp VNTR or OPRM1 A118G.
Conclusions: Previous studies identified DRD2 Taq1A A1-allele carriers as vulnerable to developing nicotine dependence.
However, this study showed that parental smoking increased the chances of developing dependence more rapidly for
early adolescents who are considered to be less sensitive to the rewarding effects of nicotine according to their DRD2
Taq1A genotype. It is thus especially important that these young people not be exposed to smoking in their social
environment.
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Background
Tobacco has been found to be one of the most addictive
recreational substances, and a significant proportion of
those experimenting with smoking progress to depend-
ence [1]. The literature provides strong support for the
presence of withdrawal symptoms among light and
intermittent smokers [2–4]. Craving, which refers to the
desire or urge to smoke, is commonly the first symptom
of dependence and can occur within days of initiating
smoking [2]. Among adolescent smokers, craving is by
far the most reported dependence symptom; moreover,
compared to other withdrawal symptoms, experienced
craving forms the single most important barrier to
both the attempt to quit and successful cessation of
smoking [5, 6].
The Sensitization-Homeostasis Model (SHM) offers a
theoretical framework for understanding the develop-
ment of nicotine dependence [7]. The SHM implies that
neurophysiological processes underlying nicotine de-
pendence can be set in motion when smoking one’s first
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cigarette. More specifically, the SHM proposes two dis-
tinct processes that induce craving during the phases of
initiation and intermittent smoking. First, the very first
dose of nicotine is argued to set off a cascade of neuro-
logical events in the brain involving, amongst others,
dopamine. When one smokes a cigarette, nicotine causes
the release of dopamine from the mesolimbic dopamine
system, and the release of dopamine consequently inhibits
craving. The craving symptoms that initially occur can be
controlled by smoking approximately one cigarette per
week. However, as tolerance increases, the duration of re-
lief offered by each cigarette shortens progressively [7]. If
the smoker does not restrain consumption, the latency to
craving shortens progressively over time, and this latency
is the primary determinant of changes in smoking fre-
quency [8]. In addition to being a symptom of nicotine
withdrawal, craving can also be evoked in the absence of
withdrawal by cues that have been previously paired with
nicotine intake (e.g., sensory or situational cues, such as
the smell of cigarette smoke).
Consistent with the SHM, studies among adults have
shown that differences in craving levels could be partly
explained by genetic variation in the dopamine pathway
– that is, by variations in polymorphisms in the D2 and
D4 dopamine receptor gene (DRD2 Taq1A (rs1800497)
and DRD4 48 bp VNTR) [9–11]. Activation along meso-
limbic dopamine substrates thus seems to influence the
motivational and appetitive properties (i.e., craving) of
tobacco. The DRD2 Taq1A and DRD4 48 bp VNTR
polymorphisms are associated with differences in dopa-
mine binding potential and could therefore potentially
play a role in the variation in experiencing reward after
nicotine intake [12]. Considering that craving can occur
within days after initiation, DRD2 Taq1A and DRD4
48 bp VNTR may partly shape the development of crav-
ing in novice smokers.
Studies on genetic variation in adolescent craving are
scarce. One study showed that DRD2 Taq1A seems to
be associated with both smoking continuation and pro-
gression to nicotine dependence in adolescents [13].
DRD4 48 bp VNTR has been associated with smoking
more frequently (implying a shorter latency to craving)
[14, 15] but not directly with measures of nicotine de-
pendence [13]. Also, a recent review concluded that
there was no strong evidence supporting an association
between the DRD2 Taq1A polymorphism and smoking
behavior [16]. So far, no studies have looked at the asso-
ciation between the DRD2 Taq1A and DRD4 48 bp
VNTR polymorphisms in the initial occurrence and pro-
gression of craving in early phases of tobacco use.
Narrowly defined phenotypes such as the initial develop-
ment of craving might be better suited for molecular
genetic studies than the often-used Fagerström Test for
Nicotine Dependence [17] or DSM-categorizations for
nicotine dependence (DSM-III-R, DSM-IV or DSM-V;
American Psychiatric Association, 1987, 1994, 2013),
which are not principally designed to measure the earlier
stages of nicotine dependence.
In addition to genetic polymorphisms in candidate
genes related to dopaminergic neurotransmission, gen-
etic polymorphism related to the opioid system may also
affect the onset and progression of craving symptoms.
According to the incentive salience theory, the dopamin-
ergic processes may become particularly relevant after
repeated exposure to nicotine [18]. The initial phase of
nicotine intake is thought to be mainly characterized by
opioid neurotransmission, which is involved in the sub-
jective pleasure (‘liking’) derived from the substance
[19]. ‘Liking’ processes and opioid neurotransmission
may thus be particularly relevant in the initiation phase.
We will therefore also include the μ-opioid receptor
OPRM1 A118G polymorphism (rs1799971). A recent re-
view on the role of OPRM1 A118G in smoking behav-
iour suggests that there is evidence for the involvement
of the OPRM1 118A-allele in nicotine reinforcement
and dependence [20]. Only one of the reviewed studies
looked at craving as an aspect of nicotine dependence
specifically, and it found no relation between OPRM1
A118G and craving [21]. Also, studies on the OPRM1
A118G genotype in adolescent samples are scarce. To
our knowledge, only one study investigated the OPRM1
A118G genotype in relation to the development of ado-
lescent smoking; that study found that males who are
homozygous for the 118A-allele showed faster develop-
ment in smoking frequency (implying a role of the
118A-allele in shortening the latency to craving),
whereas in females the 118G-allele was associated with
faster development of smoking frequency [22].
The second process described by the SHM holds that
smoking-related environmental cues can stimulate crav-
ing. The release of dopamine functions as a signal that a
rewarding stimulus has been encountered and initializes
the association of tobacco-related environmental stimuli
with the effects of nicotine. Sensory stimuli associated
with the act of smoking, such as the smell of smoke, can
become cues. Several laboratory studies have shown that
exposure to smoking-related cues is associated with ro-
bust increases in self-reported craving, modest physio-
logical responses, biases in attentional processing of
smoking-related cues, shorter latency to smoking and in-
creased smoking behavior [23–26]. Since nicotine de-
pendence can develop quickly among novice smokers
[7], and since the regulatory executive system is not yet
fully developed in adolescents [27, 28], adolescent
smokers in the early stages of smoking may encounter
challenges in regulating or inhibiting cue-induced appe-
titive response tendencies that result from exposure to
environmental smoking cues. A greater exposure to
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smoking cues in adolescent novice smokers may thus
contribute to a shortening of the latency to craving and
to the subsequent choice to smoke a cigarette. In early
adolescence, parental smoking is one factor that seems
to be associated with the risk for nicotine dependence
[29, 30]. The association between parental smoking and
the risk of craving and subsequent dependence may be
explained by physiological as well as psychosocial pro-
cesses. Previous research has shown that exposure to
high levels of tobacco smoke in the social environment
is capable of producing plasma nicotine concentrations
that are comparable to concentrations found in active
smokers [31–33] and exposure can engender substantial
brain nicotinic acetylcholine receptor occupancy [34]. In
theory, frequent or prolonged exposure to nicotine
absorbed from passive smoke may predispose nicotine-
naive adolescents to develop nicotine dependence once
they initiate smoking. Animal studies have provided pre-
liminary evidence of physiological processes resulting
from passive smoking exposure [35, 36]. On the other
hand, psychosocial processes may also explain the asso-
ciation between parental smoking and an increased risk
of nicotine dependence in youth. Parental smoking may
shape cognitive responses to tobacco use (e.g., through
outcome expectancies) as well as actual smoking behav-
iour (e.g., through social modelling or social norms),
which may enhance adolescents’ risk of developing nico-
tine dependence. Associations between environmental
smoking and social-cognitive variables such as smoking
outcome expectancies and normative perceptions have
been established by a variety of studies [37–39]. Even
though the exact mechanisms of action need to be
further elucidated, it is well-established that parental
smoking affects adolescent initiation of smoking, as well
as adolescents’ smoking frequency and progression
towards nicotine dependence [29, 40–42]. The level of
parental smoking exposure is therefore expected to
influence the initial development of craving symptoms
in early adolescent novice smokers.
According to the SHM, both genetic and environmen-
tal factors could be involved in shaping the development
of craving symptoms in early adolescent novice smokers.
For some time now, it has been acknowledged that it is
not sufficient to know to what extent genes or environ-
ment affect behavior; rather, the interplay between the
two should be studied to better understand individual
differences in certain phenotypes, such as symptoms of
nicotine dependence. More specifically, certain genetic
polymorphisms could increase the likelihood that
adolescents will develop nicotine dependence, but the
actual manifestation of nicotine addiction might depend
on environmental factors, such as parental smoking
exposure [43, 44]. So far, candidate gene studies examin-
ing gene-environment effects on smoking and nicotine
dependence are scarce. One such study recently exam-
ined interactions between polymorphisms of the dopa-
minergic system (i.e., DRD2 Taq1A, DRD4 48 bp VNTR
and DAT1) and smoking behavior of parents, siblings
and friends in predicting smoking initiation [45]. No
significant interaction effects were reported. However,
behavioral genetic studies showed that shared environ-
mental factors played a major role in smoking initiation,
whereas the influence of genetic factors increased in
smoking persistence [46, 47]. In this regard, a recent
study found an interaction effect of the serotonin trans-
porter genotype 5-HTTLPR and poor family environ-
ment on smoking habits as well as nicotine and cotinine
levels [48]. Based on the notions of the SHM, dopamin-
ergic involvement is likely in the development of craving
symptoms; thus, we will test whether dopamine-related
genotypes interact with parental smoking exposure in
predicting increases in craving over time in novice
smokers. We will focus on two different types of craving
based on the classification scheme proposed by Singleton
and Gorelick [49]. This scheme comprises two general
categories of craving models: (1) models based on condi-
tioned mechanisms and (2) models based on cognitive
mechanisms. Conditioning or cue-reactivity models posit
that nicotine-related cues trigger craving through condi-
tioned neurologic responses. Conversely, cognitive models
are based on the assumption that responses to nicotine
and nicotine-related cues involve various cognitive pro-
cesses, such as expectations regarding the pleasant effects
of nicotine. Based on the literature described above, it is
expected that the development of both cue-induced and
cognitive craving over time will be predicted by an inter-
action between parental smoking exposure and the DRD2
Taq1A, DRD4 48 bp VNTR and OPRM1 A118G geno-
type. Identifying specific genetic and environmental
mechanisms underlying the emergence of craving among
adolescent novice smokers can be expected to lead to a
more refined understanding of the etiology of nicotine
dependence and to provide important and useful informa-
tion about the individual susceptibility of adolescents to
developing nicotine dependence.
Method
Procedure and participants
A total of 1,399 adolescents (52.6 % female) with an aver-
age age of 12.63 years (range: 11 – 14, SD = 0.59) were
recruited from 22 schools in the Netherlands at Time 1
(T1). Across the five waves, 1,360 (97.2 %), 1,230 (87.9 %),
1,183 (84.6 %), 1,188 (84.9 %), and 1,099 (78.1 %) adoles-
cents participated at Time 1 (T1), Time 2 (T2), Time 3
(T3), Time 4 (T4), and Time 5 (T5), respectively. The time
between each of the five waves was approximately four
months. Adolescents were considered smokers if they re-
ported having tried smoking at least once during one or
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more of the five measurement waves. This inclusion cri-
terion was chosen because of the notion that one’s very
first cigarette may already initiate a series of neurological
changes in the brain [7].
A total of 476 of the 1,399 respondents (34.8 %) indi-
cated that they had smoked at the time of one or more
of the five waves. Adolescents who indicated that they
had smoked were referred to the questions concerning
craving. Of the 476 smokers, we included only those
smokers who completed at least three waves and were
genotyped (N = 396).
Of the 396 participants who fulfilled these criteria,
53.3 % were male, and the average age was 12.63
(SD = 0.59) (also see Table 1). Most of the adolescents
were of Dutch origin. The participants were also taking
part in a larger longitudinal study that started in January
2010, focusing on genetic and environmental influences
on substance use among Dutch adolescents. The partici-
pants were in the first grade of secondary school at T1. At
T1, saliva samples were collected for DNA extraction
(Oragene, DNA Genotek Inc). Active, written informed
consent for gene analysis was obtained from the adoles-
cents as well as their parents. During each wave, the
participants filled out an online or paper-and-pencil ques-
tionnaire during school hours. The principal investigator
visited every school, personally provided information
about the study to teachers and students and was present
during the first assessment. Students were explicitly told
that all questions were about their regular patterns and
not exceptional situations (e.g., holidays), unless otherwise
stated. The research design for this study was evaluated
and ethically approved by an independent medical ethical
committee (METiGG, Utrecht, The Netherlands).
Power analysis
We conducted power analyses using the software
Quanto [50]. For the power calculation, we applied the
gene-environment interaction design option for con-
tinuous outcomes with independent individuals. We
used a previous nation-wide study on smoking behaviour
among Dutch adolescents aged 15–16 to determine the
input for our power analyses [51, 52]. In this study,
Table 1 Descriptive statistics for control and independent model variables
Variable Response categories Mean (SD) Response frequencies Skewness (SD)
Sex Male 53.3 % .13
Female 46.7 % (.12)
Education University preparatory 8.9 % -.19
Senior general 22.0 % (.12)
Junior general 34.2 %
Preparatory vocational 34.8 %
Ethnicity Not Dutch 4 % -.47
Dutch 96 % (.12)
Age of smoking initiation 11.67 (1.90)
Baseline smoking <1 per day 83.7 % 2.70
1-5 per day 9.6 % (.21)
6-10 per day 5.2 %
>10 per day 1.4 %
DRD2 Taq1A A2A2 64.2 % .59
A2A1/A1A1 35.8 % (.12)
DRD4 48 bp <7-repeat 64.2 % .60
VNTR ≥7-repeat 35.8 % (.12)
OPRM1 A118G AA 78.7 % 1.41
AG/GG 21.3 % (.12)
Parental smoke exposure No smoking parents 54.0 % 1.00
Smoking parent(s)/no exposure 10.2 % (.13)
One smoking parent/exposed 22.5 %
Two smoking parents/exposed by one 2.3 %
Two smoking parents/exposed by both 11.0 %
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craving was measured by four items on a six-point scale.
Craving mean scores on this measure were around 2.3
(SD = 1.03). Since our target group is smokers aged 12–13,
we take a more conservative approach with anticipated
mean craving scores of 1.5 (SD = 0.75) in our own sample.
The R2 for the environmental effect was fixed at 0.035,
and the prevalence of smoking in the environment was
fixed at 25 % (Environment; Population Prevalence: 0.25)
[53]. Main effects of genetic variation are generally quite
low; thus, the R2 for the genetic effect was fixed at 0.001.
Further, approximately 30 % of the sample was expected
to have the DRD2 Taq1A A1-allele [13], and a dominant
model for the A1-allele is assumed [13, 54]. To detect a
small interaction effect with an R2 of 0.02 with 80 % power
(alpha = .05), the sample size required to detect an inter-
action effect is 374 individuals. Hence, with a sample size
of 396 adolescents, we should be able to detect even small
interaction effects with DRD2 Taq1A. Following the same
procedure for DRD4 48 bp VNTR and OPRM1 A118G,
with 30 % and 20 % of the sample expected to have the
risk-alleles (>7 repeats for DRD4 and the presence of the
G-allele for OPRM1 A118G), 374 was indicated to be suf-
ficient to detect a significant interaction effect.
Genotyping
DNA was isolated from saliva using the Oragene system
(DNA Genotek Inc., Kanata, Ontario, Canada). The
DRD2 Taq1A (rs1800497) and OPRM1 A118G
(rs1799971) polymorphisms were genotyped using Taq-
man analysis. The DRD4 48 bp repeat polymorphism in
exon 3 of the dopamine receptor gene was genotyped
using simple sequence length analysis. A detailed de-
scription of this procedure is published elsewhere [22,
45]. All genotyping assays have been previously vali-
dated, and 5 % duplicates and blanks were included as
quality controls during genotyping. Genotyping was per-
formed in a CCKL-accredited laboratory at the Depart-
ment of Human Genetics of the Radboud University
Medical Centre in Nijmegen. Distribution of the DRD2
Taq1A, the DRD4 48 bp VNTR, and the OPRM1 A118G
genotype in the study was in accordance with the
Hardy-Weinberg equilibrium (p = .71, p = .53, p = .62,
respectively). To maximize the power of the analyses
and conform to previous studies that tested DRD2
Taq1A [55, 70], DRD4 48 bp VNTR [10, 56], and
OPRM1 A118G [20–22] in relation to substance use
outcomes, we dummy coded the polymorphisms. DRD2
Taq1A was dummy coded into 1 = non-risk (A2A2) and
2 = risk (A1A2 and A1A1). Participants’ DRD4 48 bp
VNTR genotype was dummy-coded into two categories:
1 = non-risk (short allele, fewer than 7 repeats) and 2 = risk
(7 or more repeat allele carriers, at least one long allele).
OPRM1 A118G genotype was dummy coded into 1 (AA)
and 2 (AG and GG).
Questionnaires
Adolescent smoking
Smoking behavior of adolescents was assessed at each
wave. Adolescents were asked to report, on a nine-
point scale, which stage of smoking applied to them.
Response categories ranged from 1 = ‘I have never
smoked, not even one puff ’ to 9 = ‘I smoke at least
once a day’ [29, 42, 57–59] (Please see Additional file
1 for the Questionnaires used).
Parental smoking exposure
Parental smoking was assessed using the questions:
“Does your father smoke?” and “does your mother
smoke?”. Responses options were “no, he/she has never
smoked”, “no, he/she quit smoking”, and “yes, he/she
smokes”. Responses were recoded into paternal smoking
(no, yes), maternal smoking (no, yes), and number of
smoking parents (0, 1, 2). Exposure to smoking by
father/mother was assessed using the question “Does
your father/mother smoke when you are with him/her?”
Response options were “yes” and “no.” The final measure
on smoking exposure was constructed to reflect (0)
no smoking parents, (1) smoking parent(s)/no ex-
posure, (2) one smoking parent/exposed by that parent,
(3) two smoking parents/exposed by one parent, and (4)
two smoking parents/exposed by both parents. Parental
smoking behaviour was highly stable over the five waves,
with Spearman correlations ranging between .71 and .89.
Cue-induced craving
To assess cue-induced craving, we used the cue-induced
craving subscale of the Autonomy Over Tobacco Scale
(AUTOS) [60, 61]. The four items are: “When I see
other people smoking, I want a cigarette”, “When I smell
cigarette smoke, I want a cigarette”, “When I feel
stressed, I want a cigarette”, and “After eating, I want a
cigarette”. Adolescents were asked to indicate which re-
sponse option, ranging from 1 (never) to 5 (very often)
best described them. In smokers, the AUTOS correlated
with cigarette consumption and other measures of to-
bacco use [60]. Cronbach’s alphas for this scale were .88
(T1), .86 (T2), .89 (T3), .93 (T4), and .90 (T5). An aver-
age score for cue-induced craving was computed at each
wave. Adolescents who started smoking after T1 were
given the lowest mean scale scores for the time points in
which they were not smoking yet, indicating no experi-
enced craving (total mean craving score = 1).
Cognitive craving
Cognitive craving for tobacco was assessed with five
items related to the frequency of missing, desiring,
thinking of, or longing for a cigarette; The five items
were “I desire to smoke a cigarette,” “I miss a cigarette,”
“I look forward to lighting a cigarette,” “I desire to inhale
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the smoke from a cigarette,” and “I think about the nice
feeling of deeply inhaling the smoke from a cigarette”
[62]. Answers were on a five-point scale, ranging from
‘never’ to ‘very often’. Cronbach’s alphas for this scale
were .95 (T1), .95 (T2), .96 (T3), .95 (T4), and .95 (T5).
An average score for cognitive craving was computed at
each wave.
Strategy of analyses
Pearson and Spearman correlations were computed to
assess the associations between the model variables.
Descriptive statistics will be provided. The relation be-
tween the independent variables and the development of
craving was examined with a latent growth curve model
(LGC) using Mplus [63]. This approach is suitable, as
individuals do not start at the same level of craving or
progress at the same rate. LGC can determine which
variables account for these individual variations.
First, we assessed the single growth curves of cue-
induced craving and cognitive craving from Time 1 to
Time 5 by estimating the initial level (intercept) and the
rate of change over time (slope) for both craving out-
come measures. Second, DRD2 Taq1A, DRD4 48 bp
VNTR, OPRM1 A118G, and smoking exposure of par-
ents were included as predictor variables to assess
whether these variables were predictive of initial values
or growth over time of the three craving measures. In a
final step, we examined interaction effects on the initial
values and growth between DRD2 Taq1A and smoking
exposure of parents. This process was repeated for the
OPRM1 A118G and DRD4 48 bp VNTR genotypes, re-
spectively. All models were controlled for the following
variables: sex, age of smoking initiation, educational
level, ethnicity and smoking behavior as reported on the
first measurement [42]. Within Mplus, parameters were
estimated with maximum likelihood estimation with ro-
bust standard errors (MLR) to accommodate for skew-
ness of the data. Full information maximum likelihood
(FIML) estimation was applied to make use of all available
data. The model fit was investigated by the following
global fit indices: Chi-square, CFI (good fit when higher
than .90), and RMSEA (good fit when lower than .08)
[64]. To avoid chance capitalization because of the
multiple comparisons, we corrected the alpha, which was
considered significant when below 0.01.
Results
Attrition analyses
Attrition analyses were conducted in order to examine
whether those adolescents who were still participants in
the fifth wave of the study (n = 1,099; 78.1 %) dif-
fered from those who dropped out before the fifth wave
(n = 300; 22.9 %). T-tests and Chi-square tests showed no
significant differences (p > .05) in age, ethnicity, DRD2
Taq1A, DRD4 48 bp VNTR and OPRM1 A118G genotype
at T1 between participating adolescents and drop-
outs. Participants lost to follow-up were more likely
to be male [χ2(1, N = 1399) = 4.28; p < .05], to be less
educated [χ2(1, N = 1399) = 23.36; p < .001] and to be
smokers [χ2(1, N = 1399) = 14.96; p < .001].
Descriptive statistics
The means and standard deviations for the five measures
of cue-induced craving and cognitive craving are pre-
sented in Table 2. The mean levels of both types of crav-
ing are relatively low (<1.6 on a 5-point scale), indicating
that a large part of the sample reported little craving. On
average, participants scored significantly higher on cog-
nitive craving compared to cue-induced craving at all
time points. The mean levels of both types of craving
seem to increase over time. The percentage of regular
smokers (those who smoked at least once a week) also
increases over time, with 5.9 % at T1, 7.4 % at T2, 10.9 %
at T3, 14.1 % at T4 and 15.9 % at T5. Descriptive findings
for the genetic polymorphisms are also found in Table 2.
Correlations
Correlations between the model variables are presented
in Table 3. These findings show that the measures of
cue-induced and cognitive craving show mostly sig-
nificant positive correlations, with the exceptions of cue-
induced craving at T2 and cognitive craving at T5 and
of cue-induced craving at T5 and cognitive craving at
T1. Regarding the relation between cue-induced and
cognitive craving and the genotypes DRD2 Taq1A,
DRD4 48 bp VNTR and OPRM1 A118G, significant cor-
relations were found only for DRD2 Taq1A. DRD2
Taq1A was positively associated with cue-induced crav-
ing at T2 and T3 and with cognitive craving at T1 and
T2, indicating that adolescent DRD2 Taq1A A1-allele
carriers report more craving. Parental smoking exposure
at T1 was positively correlated with all craving measures,
Table 2 Descriptive statistics for dependent model variables
(N = 396)
T1 T2 T3 T4 T5
Cue-induced craving
Mean 1.27 1.29 1.37 1.50 1.36
(SD) (.59) (.62) (.73) (.91) (.70)
Skewness 3.37 2.94 2.63 2.01 2.43
(SD) (.19) (.18) (.17) (.16) (.16)
Cognitive craving
Mean 1.38 1.38 1.44 1.57 1.50
(SD) (.70) (.81) (.81) (.95) (.85)
Skewness 2.67 2.85 2.39 1.81 1.88
(SD) (.19) (.18) (.17) (.17) (.17)
For both measures: min = 1, max = 5
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with the exception of cue-induced craving at T4 and T5
and cognitive craving at T5.
Model findings
First, we tested the latent growth model for cue-induced
craving without predictors. The model showed a rea-
sonable fit to the data (χ2 [df = 10, p < .001] = 144.37,
CFI = .87, RMSEA = .07). The means and variances of
both intercept and slope were significant (respectively,
mean = 1.21, p < .001; variance = .17, p < .01 and mean = .08,
p < .001; variance = .06, p < .001), suggesting that the par-
ticipants scored greater than zero on craving symptoms at
baseline, that craving generally increased over time, and
that participants differed around the means. The associ-
ation between the intercept and the slope was not sig-
nificant (β = −.20, p = .20). Quadratic trends were also
examined but were not found to be significant.
Themodelforcognitivecravingshowedagoodfittothedata
(χ2 [df = 10,p < .001] = 155.58,CFI = .94,RMSEA = .04).The
means and variances of both intercept and slope were sig-
nificant (respectively, mean = 1.31, p < .001; variance = .28,
p < .01 and mean = .06, p < .01; variance = .06, p < .001),
suggesting that the participants scored greater than
zero on craving symptoms at baseline, that craving
generally increased over time, and that participants differ
around the means. The association between the intercept
and the slope was not significant (β = −.17, p < .39).
Finally, the possibility of a quadratic trend was examined,
but this was not found to be significant.
Second, the predictors and control variables were
added to the growth models of cue-induced and cogni-
tive craving. These models fit the data well (χ2 [df = 36,
p = .27] = 40.64, CFI = .98, RMSEA = .02; χ2 [df = 36,
p = .29] = 40.15, CFI = .98, RMSEA = .02). The control
variable of smoking behavior, as measured at T1, was posi-
tively associated with the initial values of both cue-
induced and cognitive craving (see Table 4). DRD2 Taq1A
was marginally associated (p = .01) with the intercept of
cognitive craving. DRD2 Taq1A A1-carriers seem to have
higher initial cognitive craving levels. No other associa-
tions between the parental smoke exposure, DRD2 Taq1A,
DRD4 48 bp VNTR, OPRM1 A118G and control variables
on the one hand, and the slopes of cue-induced and cogni-
tive craving on the other hand, were found.
In a final step, the interactions were included in the
model. For both cue-induced and cognitive craving, sig-
nificant interaction effects were found for DRD2 Taq1A
with parental smoke exposure (Table 4). Adolescent A1-
allele carriers do not seem to be influenced by the envir-
onment with regard to the development of cue-induced
and cognitive craving (Figs. 1 and 2). Adolescents with
the A2A2 genotype who are exposed to parental smok-
ing increase most profoundly in craving over time. No
significant interaction effects were found between DRD4
Table 3 Spearman and Pearson correlations between the model variables
1. 2. 3. 4. 5. 6. 7. 8. 9. 10. 11. 12. 13. 14. 15. 16. 17.
1. Sex -
2. Age -.04 -
3. Education -.09 -.16 -
4. Ethnicity -.06 -.08 -.17 -
5. DRD2 Taq1A -.10 .10 -.05 -.06 -
6. DRD4 VNTR .13 -.02 -.03 .04 -.04 -
7. OPRM1 A118G .09 .00 .06 -.05 -.02 .06 -
8. Parental exposure .08 .05 -.12 -.01 -.04 .03 .02 -
9. Cue Craving T1 .11 .04 -.04 .02 .13 .04 .08 .19 -
10. Cue Craving T2 .15 .15 .01 -.08 .15 .07 .12 .19 .53 -
11. Cue Craving T3 .24 .08 -.01 -.05 .15 -.02 -.01 .20 .50 .67 -
12. Cue Craving T4 .20 .13 .02 -.06 .02 -.09 .09 .11 .29 .53 .72 -
13. Cue Craving T5 .14 .03 -.04 .04 -.06 -.05 -.01 .13 .29 .26 .35 .58 -
14. Cog Craving T1 .13 .09 -.07 -.02 .18 .03 .08 .25 .82 .62 .58 .33 .19 -
15. Cog Craving T2 .08 .12 .02 -.03 .19 .06 .12 .20 .42 .91 .72 .53 .25 .57 -
16. Cog Craving T3 .16 .04 -.02 .02 .11 -.01 .00 .15 .43 .59 .89 .74 .32 .54 .67 -
17. Cog Craving T4 .19 .13 -.03 -.07 .06 -.12 .08 .15 .35 .56 .68 .93 .55 .46 .59 .74 -
18. Cog Craving T5 .10 .00 .01 .03 -.04 .01 .05 .11 .37 .19 .43 .59 .77 .36 .22 .51 .65
‘Cue’ refers to Cue-induced and ‘Cog’ refers to Cognitive; Correlations with p < .05 are in italics, correlations with p < .01 are in boldface. Spearman correlations are
underlined, all other correlations are Pearson correlations.
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48 bp VNTR and parental smoke exposure on either
craving measure. Similarly, no significant interaction ef-
fects were found for OPRM1 A118G and parental smoke
exposure on either of the measures.
Discussion
As expected, we found that early adolescents’ cognitive
as well as cue-induced craving symptoms increased over
time. The occurrence and increase of craving symptoms
conforms to the notion of the SHM that craving is com-
monly the first symptom of dependence among novice
smokers [7]. Thus, urges to smoke are to be expected
even in irregular smokers. This is conceivable since low-
frequency smokers might not smoke at all if they did
not experience cravings [65]. Even though both cue-
induced and cognitive craving levels were relatively low,
our findings indicate that these craving symptoms may
already be present in early adolescent novice smokers
and significantly increase within a short period of time.
No significant main effects of the DRD2 Taq1A, DRD4
48 bp VNTR and OPRM1 A118G genotypes were found
on the baseline levels or on changes in craving. The ab-
sence of these main gene effects is in line with previous
studies that suggested that genetic predispositions are
most likely to increase the development of dependence
if specific environmental factors are present [43, 44]. In
our study, we indeed found evidence of an interaction
between the DRD2 Taq1A polymorphism and parental
smoke exposure in the development of cognitive and
cue-induced craving symptoms over time. The absence
of a direct effect of parental smoke exposure on craving,
however, was contrary to our expectations, since
Table 4 Standardized estimates for control variables genotypes and parental smoking exposure on the intercepts and slopes of
cue-induced craving and cognitive craving
Intercept cue-induced
craving
Linear slope cue-induced
craving
Intercept cognitive
craving
Linear slope cognitive
craving
Step 1
Sex .05 .19 .10 .10
Education -.05 .10 .03 .06
Ethnicity .05 -.08 .07 -.11
Age of smoking initiation -.13 -.19 -.08 -.18
Baseline smoking .81** -.31 .72** -.35
DRD2 Taq1A .15 -.11 .22* -.21
DRD4 48 bp VNTR .06 -.06 .09 -.14
OPRM1 A118G .08 .01 .09 .02
Parental smoke exposure .07 .08 .12 -.01
Explained variance (R2) 76 % 21 % 65 % 27 %
Step 2
DRD2**Parental smoke exposure .55 -.76** .52 -.96**
DRD4**Parental smoke exposure .32 .25 .49 -.08
OPRM1**Parental smoke exposure .02 -.30 -.20 -.18
Gender: 0 =male and 1 = female, Ethnicity: 0 = Dutch and 1 = Not Dutch
*p = .01, **p < .001
Fig. 1 The moderating effect of DRD2 Taq1A and parental smoke exposure on the slope of cue-induced craving
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previous studies found that environmental smoking in-
creases the risk for both smoking initiation and nicotine
dependence in the future [40, 66–68]. However, ado-
lescents who were homozygous for the DRD2 Taq1A
A2-allele and were also highly exposed to parental
smoking did show a stronger increase of both cognitive
craving and cue-induced craving over time. Although
DRD2 Taq1A interactions with environmental factors
have rarely been studied in regard to smoking and nico-
tine dependence, our findings are in line with studies
showing DRD2 Taq1A to interact with environmental
factors in shaping addictive behaviors or personality traits
related to addictive behaviors. For example, interactions
between DRD2 Taq1A and both pre- and postnatal to-
bacco smoke exposure were found in the development of
attention, irritable reactivity and self-regulation [69]. Also,
DRD2 Taq1A was found to interact with parental rule-
setting in shaping adolescents’ alcohol use [70].
With regard to DRD2 Taq1A, we found that in the
case of no or low parental smoke exposure, both A1-
allele carriers and those who were homozygous for the
A2-allele show relatively little increase in craving over
time. However, when exposure to parental smoking is
high, those with homozygous A2-alleles show a signifi-
cantly larger increase in both cognitive and cue-induced
craving over time compared to A1-allele carriers. This
finding is remarkable, since previous studies showed that
individuals with the A1-allele have reduced brain DRD2
Taq1A availability and less dopaminergic activity com-
pared to those who are homozygous for the A2-allele
[71]. It is possible that A1-carriers may compensate for
this reduced sense of reward by using substances; in other
words, they experience more rewarding feelings from the
dopamine-enhancing effects of substance use. Adolescent
smokers with the A1-allele indeed seem more likely to
progress to smoking persistence and, eventually, depend-
ence [13]. However, we found that, in the case of the
development of initial craving symptoms, homozygosity
for the DRD2 Taq1A A2-allele is associated with a higher
vulnerability to develop these symptoms over time if ex-
posed to parental smoking. A1-carriers seem to develop
craving symptoms largely independent of parental smoke
exposure. Parental smoke exposure might thus be a cata-
lyst of craving for adolescents homozygous for the DRD2
Taq1A A2-allele, who are proposed to experience less re-
warding feelings from nicotine and are thus less likely to
develop dependence on their own (i.e., separate from
environmental cues or influences).
No effect of OPRM1 A118G on craving was found.
These results are not in line with a recent systematic re-
view on the OPRM1 A118G polymorphism in nicotine
addiction [20], which concluded that, although effects
are generally small and mixed, the OPRM1 A118G is as-
sociated with higher dopaminergic activity and feelings
of reward in response to nicotine. Moreover, our find-
ings do not corroborate the incentive salience theory
[18], which suggests that ‘liking’ processes (allegedly as-
sociated with opioid neurotransmission) are especially
relevant in the initiation phase of smoking behaviour.
Even though craving is generally the first symptom of
dependence, even earlier phenotypes of the risk of nico-
tine dependence can be distinguished, such as sensitivity
to the first dose of nicotine (i.e., experience of rewarding
or aversive sensations). Initial sensitivity to nicotine
constitutes an early predictor of the vulnerability to de-
veloping nicotine dependence among novice smokers
[72–75]. A recent study found that the OPRM1 A118G
genotype modulated initial responses to nicotine [76].
Carriers of the G-allele of the OPRM1 A118G poly-
morphism were significantly more likely to report liking
in response to initial smoking. It could be that the opioid
system is mostly important with regard to an individual’s
very first experience with nicotine, whereas the dopamine
system becomes more prominent soon after initiation.
Also contrary to our expectations, no significant asso-
ciation was observed between the DRD4 48 bp VTNR
polymorphism and the development of craving. DRD2
Taq1A and DRD4 48 bp VNTR have been previously
found to be differentially related to refined phenotypes
in adolescent smoking [13]. In particular, 15-year olds
with the > 7 repeats allele of the DRD4 48 bp VNTR
were found to begin smoking at an earlier age and to
Fig. 2 The moderating effect of DRD2 Taq1A and parental smoke exposure on the slope of cognitive craving
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have significantly higher rates of smoking initiation.
Among adolescents who had ever smoked, the likelihood
of smoking continuation and nicotine dependence was
mostly found to be related to allelic variation in DRD2
Taq1A. No studies so far have found a direct association
between DRD4 48 bp VNTR and measures of nicotine
dependence in adolescents. The variability in effects of
DRD2 Taq1A and DRD4 48 bp VNTR can be further
substantiated by the finding that DRD4 48 bp VNTR is
associated with a dopaminergically modulated and herit-
able tendency toward excitement in response to new
experiences, which might explain the previously found
associations with smoking initiation [14, 77]. Finally,
even though an in vivo cue reactivity study among adult
smokers found support for variability in the suscepti-
bility to environmental smoking cues among different
DRD4 48 bp VNTR genotypes in relation to craving
among adult smokers [10], this effect was not replicated
in a study focusing on reactivity to dynamic smoking
cues in movies among college students [78]. The re-
searchers use the heaviness of smoking to explain the
lack of an interaction effect of cue-exposure and DRD4
48 bp VNTR. It is possible that an effect between smoke
exposure and DRD4 48 bp VNTR can only be found
among heavy smokers.
Limitations
In this study, craving was measured by means of self-
report. Although self-report measures are viewed as the
most reliable and valid assessments of subjective craving,
they are still subject to such limitations as individuals’
unwillingness or inability to report on internal processes
[79, 80]. Second, the found gene–environment interaction
might partly reflect a gene–environment correlation
(rGE), since parents’ smoking behavior may reflect their
genotype, which they may partly pass on to their offspring.
Separation of these two types of gene–environment rela-
tionship has posed a major difficulty in quantitative gen-
etic research. With molecular genetics, it is possible to
infer rGE because it can be examined directly with respect
to the identified G and the identified E [81]. We found no
significant correlations between differences in DRD2
Taq1A, DRD4 48 bp VNTR and OPRM1 A118G geno-
types of adolescents and their parental smoking exposure.
Third, single nucleotide polymorphisms (SNPs) were
tested, whereas multiple loci might be involved in the
development of initial dependence symptoms. Because of
linkage disequilibrium (i.e., non-random association be-
tween alleles), genotyping several SNPs within the ANKK1
gene (where the polymorphism DRD2 Taq1 resides) and
adjacent genes would be necessary to provide insight into
other associated variants. Also, population stratification
[82] cannot be completely ruled out. However, we do
emphasize that population stratification is unlikely
because only 4 % of the adolescents in this study were
born outside the Netherlands. Finally, it should be noted
that the present sample size was rather small, which may
have resulted in an increased risk of type II error (i.e., false
negatives). This may explain why no significant main ef-
fects of DRD2 Taq1A, DRD4 48 bp VNTR or OPRM1
A118G or significant interaction effects including these
three polymorphisms have been found. Therefore, our
findings need to be replicated in studies with larger sam-
ple sizes.
Conclusions
In sum, parental smoking increases the chances of devel-
oping dependence more rapidly for young adolescents
who are supposedly less sensitive to the rewarding effects
of nicotine according to their DRD2 Taq1A genotype. It is
thus pivotal for these children not to be exposed to
smoking.
Additional file
Additional file 1: Questionnaire. (DOC 176 kb)
Competing interests
The author declares that they have no competing interests.
Author’s contributions
MK was responsible for data collection, data analysis, reporting the study results
and writing the first draft of the manuscript. RE and JD have been involved in
further drafting the manuscript and revising it critically. All authors read and
approved the final manuscript.
Authors’ information
Not applicable.
Availability of data and materials
Not applicable.
Acknowledgements
This research was supported by the Dutch Organization for Scientific
Research (no. 451-09-009). We especially thank Marlies Naber and Angelien
Heister for setting up and performing genotyping and the research group
for Multifactorial Diseases, Department of Human Genetics, Radboud
University Nijmegen Medical Centre, The Netherlands.
Funding
The research was funded by the Dutch Organization for Scientific Research
(no. 451-09-009).
Author details
1Trimbos Institute (Netherlands Institute of Mental Health and Addiction), Da
Costakade 45, 3521 VS Utrecht, The Netherlands. 2Behavioural Science
Institute, Radboud University Nijmegen, Montessorilaan 3, 6525 HR Nijmegen,
The Netherlands. 3University of Massachusetts Medical School, 55 N Lake
Ave, Worcester, MA 01655, USA.
Received: 25 July 2014 Accepted: 28 September 2015
References
1. Kassel JD. Smoking and stress: correlation, causation, and context.
Am Psychol. 2000;55:1155–6.
2. DiFranza JR. Initial symptoms of nicotine dependence in adolescents.
Tob Control. 2000;9:313–9.
Kleinjan et al. BMC Pulmonary Medicine  (2015) 15:115 Page 10 of 12
3. DiFranza JR, Savageau JA, Fletcher K, Pbert L, O’Loughlin J, McNeill AD, et al.
Susceptibility to nicotine dependence: the Development and Assessment of
Nicotine Dependence in Youth 2 study. Pediatrics. 2007;120:e974–83.
4. Riedel BW, Robinson LA, Klesges RC, McLain-Allen B. Ethnic differences
in smoking withdrawal effects among adolescents. Addict Behav.
2003;28:129–40.
5. Bagot KS, Heishman SJ, Moolchan ET. Tobacco craving predicts lapse to
smoking among adolescent smokers in cessation treatment. Nicotine Tob
Res. 2007;9:647–52.
6. Rojas NL, Killen JD, Haydel KF, Robinson TN. Nicotine dependence among
adolescent smokers. Arch Pediatr Adolesc Med. 1998;152:151–6.
7. DiFranza JR, Wellman RJ. A sensitization-homeostasis model of nicotine
craving, withdrawal, and tolerance: integrating the clinical and basic science
literature. Nicotine Tob Res. 2005;7:9–26.
8. DiFranza JR, Wellman RJ, Mermelstein R, Pbert L, KleinJ D, Sargent JD, et al.
The Natural History and Diagnosis of Nicotine Addiction. Curr Pediatr Rev.
2011;7:88–96.
9. Erblich J, Lerman C, Self DW, Diaz GA, Bovbjerg DH. Effects of dopamine D2
receptor (DRD2) and transporter (SLC6A3) polymorphisms on smoking
cue-induced cigarette craving among African-American smokers.
Mol Psychiatry. 2005;10:407–14.
10. Hutchison KE, LaChance H, Niaura R, Bryan A, Smolen A. The DRD4 VNTR
polymorphism influences reactivity to smoking cues. J Abnorm Psychol.
2002;111:134–43.
11. Vandenbergh DJ, O’Connor RJ, Grant MD, Jefferson AL, Vogler GP, Strasser A a,
et al. Dopamine receptor genes (DRD2, DRD3 and DRD4) and gene-gene
interactions associated with smoking-related behaviors. Addict Biol.
2007;12:106–16.
12. Brody AL, Mandelkern MA, Olmstead RE, Scheibal D, Hahn E, Shiraga S, et al.
Gene variants of brain dopamine pathways and smoking-induced
dopamine release in the ventral caudate/nucleus accumbens. Arch Gen
Psychiatry. 2006;63:808–16.
13. Laucht M, Becker K, Frank J. Genetic Variation in Dopamine Pathways
Differentially Associated With Smoking Progression in Adolescence. J Am
Acad Child Adolesc Psychiatry. 2008;47:673–81.
14. Laucht M, Becker K, El-Faddagh M, Hohm E, Schmidt MH. Association of the
DRD4 exon III polymorphism with smoking in fifteen-year-olds: a mediating
role for novelty seeking? J Am Acad Child Adolesc Psychiatry. 2005;44:477–84.
15. Shields PG, Lerman C, Audrain J, Bowman ED, Main D, Boyd NR, et al. Dopamine
D4 receptors and the risk of cigarette smoking in African- Americans and
Caucasians. Cancer Epidemiol Biomarkers Prev. 1998;7:453–8.
16. Munafò MR, Timpson NJ, David SP, Ebrahim S, Lawlor DA. Association of the
DRD2 gene Taq1A polymorphism and smoking behavior: a meta-analysis
and new data. Nicotine Tob Res. 2009;11:64–76.
17. Heatherton TF, Kozlowski LT, Frecker RC, Fagerstrom K-O. Fagerstrom test for
nicotine dependence Br J Addiction 1991.pdf. Br J Addict. 1991;86:1119–27.
18. Robinson TE, Berridge KC. Addiction. Annu Rev Psychol. 2003;54:25–53.
19. Berridge KC. Pleasures of the brain. Brain Cogn. 2003;52:106–28.
20. Verhagen M, Kleinjan M, Engels RCME. A systematic review of the A118G
(Asn40Asp) variant of OPRM1 in relation to smoking initiation, nicotine
dependence and smoking cessation. Pharmacogenomics. 2012;13:917–33.
21. Ray R, Jepson C, Patterson F, Strasser A, Rukstalis M, Perkins K, et al.
Association of OPRM1 A118G variant with the relative reinforcing value of
nicotine. Psychopharmacology (Berl). 2006;188:355–63.
22. Kleinjan M, Poelen EA, Engels RCME, Verhagen M. Dual growth of adolescent
smoking and drinking: evidence for an interaction between the mu-opioid
receptor (OPRM1) A118G polymorphism and sex. Addict Biol. 2012.
23. Carter BL, Tiffany SENT. A Meta-analysis of cue-reactivity in addiction
research. Addiction. 1999;94:327–40.
24. Droungas A, Ehrman RN. Childress a R, O’Brien CP: Effect of smoking cues
and cigarette availability on craving and smoking behavior. Addict Behav.
1995;20:657–73.
25. Field M, Cox WM. Attentional bias in addictive behaviors: A review of its
development, causes, and consequences. Drug Alcohol Depend. 2008;97:1–20.
26. Payne TJ, Schare ML, Levis DJ, Colletti G. Exposure to Smoking-Relevant
Cues: Effects on Desire to Smoke and Topographical Components of
Smoking Behavior. Addict Behav; 1991;16:467–79.
27. Steinberg L. A Social Neuroscience Perspective on Adolescent Risk-Taking.
Dev Rev. 2008;28:78–106.
28. Wiers RW, Bartholow BD, van den Wildenberg E, Thush C, Engels RCME,
Sher KJ, et al. Automatic and controlled processes and the development of
addictive behaviors in adolescents: A review and a model. Pharmacol
Biochem Behav. 2007;86:263–83.
29. Kleinjan M, Engels RCME, van Leeuwe J, Brug J, van Zundert RMP,
van den Eijnden RJJM. Mechanisms of adolescent smoking cessation: roles
of readiness to quit, nicotine dependence, and smoking of parents and
peers. Drug Alcohol Depend. 2009;99:204–14.
30. Okoli CTC, Richardson CG, Johnson JL. An examination of the relationship
between adolescents’ initial smoking experience and their exposure to peer
and family member smoking. Addict Behav. 2008;33:1183–91.
31. Al-Delaimy WK, Crane J, Woodward A. Passive smoking in children: effect
of avoidance strategies, at home as measured by hair nicotine levels.
Arch Environ Health. 2001;56:117–22.
32. Dimich-Ward H, Gee H, Brauer M, Leung V. Analysis of nicotine and cotinine
in the hair of hospitality workers exposed to environmental tobacco smoke.
J Occup Environ Med Am Coll Occup Environ Med. 1997;39:946–8.
33. Jarvis MJ, Russell MA, Feyerabend C. Absorption of nicotine and carbon
monoxide from passive smoking under natural conditions of exposure.
Thorax. 1983;38:829–33.
34. Brody AL, Mandelkern MA, London ED, Khan A, Kozman D, Costello MR,
et al. Effect of secondhand smoke on occupancy of nicotinic acetylcholine
receptors in brain. Arch Gen Psychiatry. 2011;68:953–60.
35. Small E, Shah HP, Davenport JJ, Geier JE, Yavarovich KR, Yamada H, et al.
Tobacco smoke exposure induces nicotine dependence in rats.
Psychopharmacology (Berl). 2010;208:143–58.
36. Yamada H, Bishnoi M, Keijzers KFM, Van Tuijl IA, Small E, Shah HP, et al.
Preadolescent tobacco smoke exposure leads to acute nicotine dependence
but does not affect the rewarding effects of nicotine or nicotine withdrawal in
adulthood in rats. Pharmacol Biochem Behav. 2010;95:401–9.
37. Otten R, Engels RCME, Prinstein MJ. A prospective study of perception in
adolescent smoking. J Adolesc Health. 2009;44:478–84.
38. Racicot S, McGrath JJ, O’Loughlin J. An investigation of social and
pharmacological exposure to secondhand tobacco smoke as possible
predictors of perceived nicotine dependence, smoking susceptibility, and
smoking expectancies among never-smoking youth. Nicotine Tob Res.
2011;13:926–33.
39. Schuck K, Otten R, Engels RCME, Kleinjan M. The relative role of nicotine
dependence and smoking-related cognitions in adolescents’ process of
smoking cessation. Psychol Heal. 2011;26:1310–26.
40. Leonardi-Bee J, Jere ML, Britton J. Exposure to parental and sibling smoking
and the risk of smoking uptake in childhood and adolescence: a systematic
review and meta-analysis. Thorax. 2011;66:847–55.
41. Hu M-C, Davies M, Kandel DB. Epidemiology and correlates of daily smoking
and nicotine dependence among young adults in the United States. Am J
Public Health. 2006;96:299–308.
42. De Leeuw RNH, Engels RCME, Vermulst AA, Scholte RHJ. Relative risks of
exposure to different smoking models on the development of nicotine
dependence during adolescence: a five-wave longitudinal study. J Adolesc
Health. 2009;45:171–8.
43. Rutter M. Genes and Behavior; Nature-Nurture Interplay Explained. Malden,
MA: Blackwell Publishing; 2006.
44. Rutter M, Silberg J. Gene-environment interplay in relation to emotional and
behavioral disturbance. Annu Rev Psychol. 2002;53:463–90.
45. Hiemstra M, Kleinjan M, van Schayck OCP, Engels RCME, Otten R.
Environmental smoking and smoking onset in adolescence: the role of
dopamine-related genes. Findings from two longitudinal studies PLoS One.
2014;9:e86497.
46. Koopmans JR, Slutske WS. The genetics of smoking initiation and quantity
smoked in Dutch adolescent and young adult twins. Behav Genet.
1999;29:383–93.
47. Vink JM, Willemsen G, Boomsma DI. Heritability of smoking initiation and
nicotine dependence. Behav Genet. 2005;35:397–406.
48. Nilsson KW, Oreland L, Kronstrand R, Leppert J. Smoking as a product of
gene-environment interaction. Ups J Med Sci. 2009;114:100–7.
49. Singleton EG, Gorelick DA. Mechanisms of alcohol craving and their clinical
implications. Recent Dev Alcohol. 1998;14:177–95.
50. Gauderman W, Morrison J: Quanto 1.2.3. A computer program for power
and sample size calculations for genetic-epidemiology studies. 2007.
51. Kleinjan M, Wanner B, Vitaro F, Van den Eijnden RJJM, Brug J, Engels RCME.
Nicotine dependence subtypes among adolescent smokers: examining the
occurrence, development and validity of distinct symptom profiles. Psychol
Addict Behav. 2010;24:61–74.
Kleinjan et al. BMC Pulmonary Medicine  (2015) 15:115 Page 11 of 12
52. Kleinjan M, Vitaro F, Wanner B, Brug J, Van den Eijnden RJJM, Engels RCME.
Predicting nicotine dependence profiles among adolescent smokers: the
roles of personal and social-environmental factors in a longitudinal
framework. BMC Public Health. 2012;12:196.
53. Stivoro: Smoking: The Hard Facts (Roken, de Harde Feiten). Den Haag; 2012.
54. Audrain-McGovern J, Rodriguez D, Wileyto EP, Schmitz KH, Shields PG. Effect
of team sport participation on genetic predisposition to adolescent
smoking progression. Arch Gen Psychiatry. 2006;63:433–41.
55. Bau CHD, Almeida S, Hutz MH. The Taq1 A1 allele of the dopamine D2
receptor gene and alcoholism in Brazil. Am J Med Genet. 2000;96:302–6.
56. Larsen H, Van der Zwaluw CS, Overbeek G, Granic I, Franke B, Engels RCME.
The DRD4 genotype and social adaptation of alcohol use: a geneenvironment
interaction. Psych Science. 2010;21:1064–8.
57. Harakeh Z, Scholte RHJ, de Vries H, Engels RCME. Parental rules and
communication: their association with adolescent smoking. Addiction.
2005;100:862–70.
58. Kleinjan M, Brug J, van den Eijnden RJJM, Vermulst AA, van Zundert RMP,
Engels RCME. Associations between the transtheoretical processes of
change, nicotine dependence and adolescent smokers’ transition through
the stages of change. Addiction. 2008;103:331–8.
59. Kremers SP, Mudde AN, de Vries H. Subtypes within the precontemplation
stage of adolescent smoking acquisition. Addict Behav. 2001;26:237–51.
60. DiFranza JR, Wellman RJ, Ursprung WWSA, Sabiston C. The Autonomy
Over Smoking Scale. Psychol Addict Behav J Soc Psychol Addict Behav.
2009;23:656–65.
61. DiFranza JR, Sweet M, Savageau JA, Ursprung WWS. The assessment of
tobacco dependence in young users of smokeless tobacco. Tob Control.
2012;471–476.
62. Dijkstra A, Borland R. Residual outcome expectations and relapse in
ex-smokers. Heal Psychol. 2003;22:340–6.
63. Muthén BO, Muthén LK. Mplus User’s Guide (sixth edition). Los Angeles:
Muthén & Muthén; 2007.
64. Hu L, Bentler PM. Cutoff criteria for fit indexes in covariance structure
analysis: Conventional criteria versus new alternatives. Struct Equ Model A
Multidiscip J. 1999;1–55.
65. Zhu SH, Pulvers K. Beyond withdrawal symptoms: response to DiFranza.
Addiction. 2008;103:512–3.
66. Becklake MR, Ghezzo H, Ernst P. Childhood predictors of smoking in
adolescence: a follow-up study of Montreal schoolchildren. Can Med Assoc
J. 2005;173:377–9.
67. Bernat DH, Erickson DJ, Widome R, Perry CL, Forster JL. Adolescent smoking
trajectories: results from a population-based cohort study. J Adolesc Heal.
2008;43:334–40.
68. Kleinjan M, Van den Eijnden RJJM, Van Leeuwe J, Brug J, Van de Ven, MOM,
Engels, RCME. Adolescents’ movement towards cessation of smoking: Role
and relative value of the processes of change and nicotine dependence.
Psychol Health. 2008;23:729-743.
69. Wiebe SA, Espy KA, Stopp C, Respass J, Stewart P, Jameson TR, et al.
Gene-environment interactions across development: Exploring DRD2
genotype and prenatal smoking effects on self-regulation. Dev Psychol.
2009;45:31–44.
70. Van der Zwaluw CS, Engels RCME, Vermulst AA, Franke B, Buitelaar J,
Verkes RJ, et al. Interaction between dopamine D2 receptor genotype
and parental rule-setting in adolescent alcohol use: evidence for a
gene-parenting interaction. Mol Psychiatry. 2010;15:727–35.
71. Noble EP, Blum K, Ritchie T, Montgomery A, Sheridan PJ. Allelic association
of the D2 dopamine receptor gene with receptor-binding characteristics in
alcoholism. Arch Gen Psychiatry. 1991;48:648–54.
72. DiFranza JR, Savageau JA, Rigotti NA, Ockene JK, McNeill AD, Coleman M,
et al. Trait anxiety and nicotine dependence in adolescents: a report from
the DANDY study. Addict Behav. 2004;29:911–9.
73. Kandel DB, Hu M-C, Griesler PC, Schaffran C. On the development of
nicotine dependence in adolescence. Drug Alcohol Depend. 2007;91:26–39.
74. Sartor CE, Lessov-Schlaggar CN, Scherrer JF, Bucholz KK, Madden PAF,
Pergadia ML, et al. Initial response to cigarettes predicts rate of progression
to regular smoking: findings from an offspring-of-twins design. Addict
Behav. 2010;35:771–8.
75. Difranza JR, Savageau JA, Fletcher K, Pbert L, Loughlin O, Mcneill AD, et al.
Susceptibility to Nicotine Dependence : The Development and Assessment
of Nicotine Dependence in Youth 2 Study. Arch Pediatr Adolesc Med.
2007;161:704–10.
76. Schuck K, Otten R, Engels RCME, Kleinjan M. Initial responses to the first
dose of nicotine in novel smokers: The role of exposure to environmental
smoking and genetic predisposition. Psychol Health. 2014;29:698–716.
77. Cloninger CR, Svrakic DM, Przybeck TR. A psychobiological model of
temperament and character. Arch Gen Psychiatry. 1993;50:975–90.
78. Lochbuehler K, Verhagen M, Munafò MR, Engels RCME. Lack of association
of DRD4 exon 3 VNTR genotype with reactivity to dynamic smoking cues in
movies. Drug Alcohol Depend. 2013;132:324–8.
79. Field M, Munafò MR, Franken IHA. A meta-analytic investigation of the
relationship between attentional bias and subjective craving in substance
abuse. Psychol Bull. 2009;135:589–607.
80. Singleton E, Moolchan E, Heishman S. Tobacco Craving Questionnaire:
Reliability and validity of a new multifactorial instrument. Nicotine Tob Res.
2003;5:645–54.
81. Rutter M. Biological implications of gene-environment interaction. J Abnorm
Child Psychol. 2008;36:969–75.
82. Marchini J, Cardon LR, Phillips MS, Donnelly P. The effects of human
population structure on large genetic association studies. Nat Genet.
2004;36:512–7.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Kleinjan et al. BMC Pulmonary Medicine  (2015) 15:115 Page 12 of 12
